From MarketBeat:

Coloplast A/S saw a 62.5% growth in short interest during December, leading to a total of 1,300 shares. With an average trading volume of 121,700 shares, the days-to-cover ratio is 0.0 days.

Wall Street analysts have given Coloplast A/S a “Hold” average rating, with a consensus price target of $815.00. The company has an average rating of “Hold,” with a sell rating from one analyst.

Coloplast A/S stock is currently trading at $11.53, with a market capitalization of $24.90 billion and a price-to-earnings ratio of 41.18. The company’s fifty-two week low is $9.90 and high is $14.77.

Coloplast A/S recently raised its dividend to $0.1498, compared to the previous $0.05 dividend. The company’s payout ratio is currently 27.50%.

Coloplast A/S operates segments in intimate healthcare products and services, including Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care.

MarketBeat provides analysis and ratings on stocks. Although Coloplast A/S has a “Hold” rating, MarketBeat identified five other stocks recommended by top analysts. The company offers a list of seven best retirement stocks.



Read more: Coloplast A/S (OTCMKTS:CLPBY) Short Interest Update